CytomX Therapeutics (CTMX) Beats Q1 Earnings and Revenue Estimates

CytomX Therapeutics (CTMX) came out with quarterly earnings of $0.27 per share, beating the Zacks Consensus Estimate of$ 0.18 per share. This compares to earnings of $0.17 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 50%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of$ 0.20 per share when it actually produced earnings of $0.22, delivering a surprise of 210%. Over the last four quart ...